Trial
NCT04704843
A Study of Guselkumab in Adult Participants With Celiac Disease
Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Janssen Research & Development, LLC
Collaborators
—
Condition
Celiac Disease
Intervention
Guselkumab
Why stopped
Study terminated. Sponsor decision.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-02-03